Sodium Diuril
Product Images NDC 76478-711

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Diuril (NDC 76478-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sod07 0009 01

FDA Label Image

Sod07 0009 02

FDA Label Image

Sod07 0009 03

FDA Label Image

Sod07 0009 04

Sod07 0009 04
This is a description for an intravenous medication named "Sodium Diuril" which has chlorothiazide equivalent components. It comes in the form of single-dose vials that can be reconstituted by adding a minimum of 18 mL of sterile water or injection. The medication is used intravenously and should be used immediately after reconstitution. The unused solution should be discarded. The accompanying text provides information about the contents of the vial and the intended dosage for adults. The product is distributed by Akorn Operating Company LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.